2 SCIENTIFIC SESSIONS DAILY NEWS | Monday, Nov. 9, 2026 Obesity Summit OBES.01 | Obesity Module 1: Overview and Understanding Obesity/Complexity and Origins of Obesity 9:30–9:50 a.m. | S105D OBES.02 | Obesity Module 2: How to Approach the Weight Discussion/Minimizing Bias 9:50–10:10 a.m. | S105D Obesity Module 3: Supporting Lifestyle Changes 10:10–10:30 a.m. | S105D OBES.04 | Obesity Module 4: Obesity Medicine/Pharmacologic Therapies 10:30–10:50 a.m. | S105D OBES.05 | Obesity Module 5: Surgical Procedures, Access to Care, Resources 10:50–11 a.m. | S105D OBES.06 | Obesity Module 6: Weight Loss Maintenance and Panel 11–11:30 a.m. | S105D Today at Sessions All sessions are located at the McCormick Place Convention Center unless otherwise noted. Late-Breaking Science and Featured Sessions LBS.05 | Late-Breaking Science: New Frontiers in Cardiometabolic Risk Reduction 8–9:15 a.m. | Center Stage, North Hall, Level 3 LBS.ID.03 | LBS In-Depth 3 8-9:15 a.m. | S103D FS.11 | Silencing ATTR-CM: Lessons From Helios-B and CardioTransform* 9:30–10:45 a.m. | Learning Studio 2, Science & Technology Hall JRNL.10 | GLP1 and Implications for Cardiometabolic and Cardiopulmonary Medicine: Henning Lecture 2026 9:45–11 a.m. | S102A LBS.06 | Late-Breaking Science: Artificial Intelligence in the Diagnosis of Cardiovascular Disease 9:45–11 a.m. | Center Stage, North Hall, Level 3 FS.12 | Featured Science Potpourri* 1:30–2:45 p.m. | Heart Theater 2, Science & Technology Hall, Heart Hub FS.13 | Practice Informing RCTs* 1:30–2:45 p.m. | Learning Studio 2, Science & Technology Hall View the Industry Programming Guide for today’s events. Congenital Heart Disease Day Supported by Mussallem CHD Alliance CP.CVS.23 | Driving Progress in CHD: Where Research, Innovation and Clinical Care Meets Advocacy and Policy 8–9:15 a.m. | S100A CP.CVS.24 | Advances in Digital and Device-Based Monitoring for Children With CHD 9:45–11 a.m. | S100A CP.CVS.25 | The Journey Beyond Survival: What Matters Most to People Living With Congenital Heart Disease 11:15–11:45 a.m. | S100A CP.CVS.26 | “Is This the Moment?” Investment Panel Noon–1 p.m. | S100A Advancing Care in HFmrEF/HFpEF: Optimizing Therapies for Better Outcomes Request a Presentation Today! spotlight.heart.org Heart Failure affects approximately 6.7 million Americans age 20 and older and the need for effective care management continues to grow. Empower your team to enhance care for patients with heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF). LEARNING OBJECTIVES This program is sponsored by Bayer PAID ADVERTISEMENT © Copyright 2026 American Heart Association, Inc., a 501(c)(3) not-for-profit. All rights reserved. Unauthorized use prohibited. WF-1903575 9/26 • Early Treatment Initiation • Treatment Differentiation • HFmrEF/HFpEF Disease Burden • Reducing Residual Risk FREE GRAND ROUNDS EDUCATION IN PERSON OR VIRTUALLY
RkJQdWJsaXNoZXIy MjI2NjI=